Salvianolic Acid B Inhibits LH2 to Reduce Pulmonary Fibrosis
2026-07-15
The referenced study identifies Salvianolic acid B (Dan Shen Suan B) as a potent inhibitor of lysyl hydroxylase 2 (LH2), disrupting pathological collagen cross-linking and mitigating fibrotic progression in pulmonary fibrosis models. These findings provide mechanistic clarity and highlight new directions for targeting extracellular matrix remodeling in fibrotic lung disease.
Adefovir (GS-0393) in HBV Research: Protocols and Troublesho
2026-07-14
Adefovir (GS-0393) empowers hepatitis B virus (HBV) research with unmatched specificity for DNA polymerase inhibition and renal transporter assays. Discover stepwise protocols, advanced applications, and actionable troubleshooting tips that transform bench workflows using APExBIO’s rigorously characterized reagent.
Synthetic Lethality via Mcl-1 Suppression and BCL-XL Inhibit
2026-07-14
This study uncovers a synergistic vulnerability in glioblastoma by combining epigenetic targeting of Mcl-1 with BCL-XL/BCL-2 inhibition. The findings define a rational strategy to overcome apoptotic resistance in aggressive brain tumors and inform experimental design for apoptosis research.
Dantrolene Sodium Salt: Mechanistic Leverage for Translation
2026-07-13
This thought-leadership article explores the transformative role of Dantrolene sodium salt as a ryanodine receptor antagonist in translational research. We delve into its molecular mechanism, recent breakthroughs in modulating DNA repair during genome editing, and strategic guidance for researchers seeking reproducible and clinically relevant results. By integrating insights from CRISPR DNA repair modulation studies with practical workflow recommendations, this piece offers a roadmap for leveraging Dantrolene sodium salt in disease modeling, synthetic lethality screens, and beyond.
PP 2 (AG 1879): Dissecting Src Kinase Pathways in Decidualiz
2026-07-13
Explore how PP 2 (AG 1879), a selective Src kinase inhibitor, enables advanced mechanistic studies in cell signaling and reproductive biology. This article uniquely connects PP 2 to recent breakthroughs in cytoskeletal remodeling during decidualization.
Hydroxytyrosol in Translational Research: Mechanism, Strateg
2026-07-12
This thought-leadership article explores the mechanistic underpinnings and translational strategies for Hydroxytyrosol—4-(2-hydroxyethyl)benzene-1,2-diol—as a precision antioxidant bioactive compound. Integrating evidence from both foundational research and the competitive landscape, the article guides translational scientists in designing robust protocols for addressing oxidative stress and inflammation, with a focus on cardiovascular and renal disease models. It also contextualizes recent advances and strategic imperatives for maximizing Hydroxytyrosol’s research value.
Aclacinomycin A: Optimizing DNA Damage and Apoptosis Assays
2026-07-10
Aclacinomycin A (Aclarubicin) stands out as a dual topoisomerase inhibitor and apoptosis inducer for high-fidelity DNA damage research. Unlock advanced protocols, troubleshooting, and comparative insights to empower cancer and genome stability workflows.
Humanized Mice Enable Accurate PK Modeling of CES Prodrug HD
2026-07-09
This study establishes humanized liver mice as a superior model for predicting human pharmacokinetics of carboxylesterase (CES) prodrugs, specifically HD56, addressing species differences that hinder translational research. The work advances methodological rigor for in vivo-in vitro correlation and offers a framework for preclinical evaluation of ester prodrugs.
Fluorescein Tyramide: Signal Amplification in IHC and ISH Wo
2026-07-09
Fluorescein Tyramide unlocks ultrasensitive detection for low-abundance targets in neural circuit mapping and molecular assays. Dive into protocol enhancements, comparative advantages over traditional labeling, and troubleshooting tips that drive reproducible results in even the most challenging tissues.
Axitinib (AG 013736): Strategic Translation in Cancer Resear
2026-07-08
This thought-leadership article explores Axitinib (AG 013736) as a paradigm-shifting tool for translational oncology, weaving mechanistic depth with practical insights for angiogenesis inhibition, advanced in vitro modeling, and tumor growth suppression. By integrating evidence-based protocol guidance and referencing innovations in drug response assessment, the article charts a credible, visionary path for cancer biology researchers.
Sulfo-NHS-SS-Biotin: Precision in Reversible Protein Labelin
2026-07-08
Explore how Sulfo-NHS-SS-Biotin enables highly selective, reversible protein labeling for advanced affinity purification and bioconjugation. This article uniquely bridges mechanistic chemistry with decision-making in proteostasis research, offering actionable insights for optimizing surface protein assays.
Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition
2026-07-07
Masitinib (AB1010) is a selective phenylaminothiazole-type tyrosine kinase inhibitor designed for precise inhibition of KIT, PDGFRα, and PDGFRβ, providing a robust approach for cancer biology, mastocytosis, and inflammation research. It should be used exclusively in DMSO-based protocols and is unsuitable for workflows requiring aqueous or ethanol solubility, or broad-spectrum kinase inhibition.
Cholesterol as a Precision Tool in Membrane Fluidity and Lip
2026-07-07
Explore cholesterol, the principal sterol, in advanced membrane and lipid metabolism research. This article offers a deeper analysis of cholesterol's biophysical roles, optimized use in research protocols, and practical insights drawn from recent breakthroughs in mRNA-LNP delivery.
Salvianolic acid B: Applied Protocols for Pulmonary Fibrosis
2026-07-06
Salvianolic acid B (Dan Shen Suan B) empowers fibrosis researchers with a reproducible, high-purity approach to inhibiting LH2-driven collagen remodeling. This guide details practical workflows, protocol optimization, and troubleshooting strategies that maximize the compound's impact in advanced pulmonary fibrosis models.
Bestatin as a Probe for Jasmonate Signaling in Arabidopsis
2026-07-06
This study demonstrates that bestatin, an aminopeptidase inhibitor, selectively activates jasmonate signaling in Arabidopsis, enabling the dissection of jasmonate-dependent gene expression and plant defense pathways. The chemical genetics approach revealed novel regulators of jasmonate responses and provides an experimental model for understanding plant hormone signaling networks.
505 records 15/34 page Previous Next First page 上5页 1112131415 下5页 Last page